IRIS
MICIACCIA, MORENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 355
EU - Europa 218
AS - Asia 75
SA - Sud America 11
OC - Oceania 1
Totale 660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 350
IT - Italia 138
CN - Cina 51
SE - Svezia 42
GB - Regno Unito 10
CZ - Repubblica Ceca 9
BE - Belgio 7
CL - Cile 7
JP - Giappone 7
IN - India 6
CA - Canada 5
HU - Ungheria 4
PE - Perù 4
KR - Corea 3
SG - Singapore 3
DE - Germania 2
IL - Israele 2
IR - Iran 2
RU - Federazione Russa 2
AU - Australia 1
BG - Bulgaria 1
EE - Estonia 1
FR - Francia 1
IE - Irlanda 1
PK - Pakistan 1
Totale 660
Salva come PNG Salva come JPEG
Città #
Sannicandro di Bari 57
Chandler 48
Nyköping 39
Fairfield 37
Ashburn 34
Bari 30
Cambridge 17
Woodbridge 16
Houston 13
Seattle 13
Beijing 12
Wilmington 10
Brno 8
New York 8
Brussels 7
Santiago 7
Ann Arbor 6
Lawrence 6
Tokyo 6
Bitonto 5
Dearborn 5
Roxbury 5
Shanghai 5
Arequipa 4
Des Moines 4
Kornye 4
Milan 4
Rome 4
Valenzano 4
Valparaiso 4
Wallsend 4
Boardman 3
Inglewood 3
Massafra 3
Nanjing 3
Racale 3
Stanford 3
Toronto 3
Alexandria 2
Altamura 2
Bedford 2
Coimbatore 2
Grottaglie 2
Hemel Hempstead 2
Irving 2
Minneapolis 2
Munich 2
Port Clinton 2
San Diego 2
San Francisco 2
Santa Marinella 2
Saskatoon 2
Tel Aviv 2
Triggiano 2
Virginia Beach 2
Wuhan 2
Wuxi 2
Adelfia 1
Altoona 1
Ardabil 1
Bloomington 1
Brisbane 1
Brooklyn 1
Changsha 1
Chengdu 1
Fort Worth 1
Harbin 1
Hebei 1
Hefei 1
Heze 1
Hounslow 1
Jiaxing 1
Jinhua 1
Livermore 1
Monmouth Junction 1
Multan 1
Musashino 1
Nanchang 1
Nantong 1
New Delhi 1
Neyshabur 1
Olomouc 1
Paris 1
Prescot 1
Princeton 1
Prineville 1
Pune 1
Redmond 1
Redwood City 1
San Mateo 1
Singapore 1
Sofia 1
Tallinn 1
Wexford 1
Zibo 1
Totale 523
Salva come PNG Salva come JPEG
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 125
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection 108
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment 85
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid 54
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders 47
Neuroinflammation and Microglial Constitutive COX-1 Inhibition 39
Ovine COX-1 Isoenzyme Bio-production 39
Three-dimensional structure of human cyclooxygenase (hCOX)-1 38
Comparative Structural Analysis of hCOX‑1 and oCOX‑1 Isoenzymes 18
Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma 16
MODULATORS OF HUMAN MITOCHONDRIAL PROTEASE ClpP ACTIVITY FOR PEDIATRIC DIFFUSE PONTINE GLIOMA TREATMENT 15
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes 14
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design 14
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG) 13
m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity 13
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer 11
A Simplified Direct O2 Consumption-Based Assay to Test COX Inhibition 11
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel mediated resistance in gastric cancer cell lines 10
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER 10
Modulation of the activity of human mitochondrial protease complex ClpXP as potential therapeutic strategy for cancer 9
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19 9
Olive Mill Wastewater Fermented with Microbial Pools as a New Potential Functional Beverage 9
Human Caseinolytic Protease P (hClpP) Activity Modulating Agents For The Treatment Of DIPG/DMG 8
Inside circular economy challenges: “green” application to valorise olive mill wastewater 6
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug. 5
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment 5
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery 4
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior 4
Design and synthesis of new [4,5-b] and [4,5-c] imidazopyridines as potential fluorophores/inhibitors for Human Cyclooxygenase-1. 2
The Tyrosine Kinases Inhibitors (TKI) Staurosporine/Midostaurin Act as Cation Channel Inhibitors with Antiproliferative Effects in DIPG36 and DIPG50 cells 1
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges 1
Potassium channels and TRPV1 modulators on SU-DIPG-36 and SU-DIPG-50 cells: in vitro effects and channel currents characterization 1
Structure-activity relationships of piperazine-2-one derivatives as novel human ClpP activators 1
Totale 745
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 10 5 4 10 7 7 7 7 9 17 9 4
2020/202187 7 4 0 8 10 8 0 8 16 15 7 4
2021/202275 10 6 1 2 2 5 2 14 3 8 9 13
2022/2023152 8 19 17 6 18 21 4 27 19 4 6 3
2023/2024295 4 14 14 24 26 18 16 7 95 35 16 26
2024/202535 35 0 0 0 0 0 0 0 0 0 0 0
Totale 745